These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 25790780)
21. MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer. Yu B; Lv X; Su L; Li J; Yu Y; Gu Q; Yan M; Zhu Z; Liu B PLoS One; 2016; 11(8):e0158961. PubMed ID: 27518872 [TBL] [Abstract][Full Text] [Related]
22. Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer. Ito T; Yamada S; Tanaka C; Ito S; Murai T; Kobayashi D; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y Ann Surg Oncol; 2014 Feb; 21(2):560-8. PubMed ID: 24046108 [TBL] [Abstract][Full Text] [Related]
23. GNA13 as a prognostic factor and mediator of gastric cancer progression. Zhang JX; Yun M; Xu Y; Chen JW; Weng HW; Zheng ZS; Chen C; Xie D; Ye S Oncotarget; 2016 Jan; 7(4):4414-27. PubMed ID: 26735177 [TBL] [Abstract][Full Text] [Related]
24. Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer. Feng L; Yao C; Li P; Feng Y; Wang F; Liu YF; Guo YB; Mao QS; Xue WJ Tumour Biol; 2016 Jul; 37(7):9399-410. PubMed ID: 26779638 [TBL] [Abstract][Full Text] [Related]
25. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F. Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692 [TBL] [Abstract][Full Text] [Related]
26. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy. Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197 [TBL] [Abstract][Full Text] [Related]
27. ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer. Zhang F; Zhang X; Meng J; Zhao Y; Liu X; Liu Y; Wang Y; Li Y; Sun Y; Wang Z; Mei Q; Zhang T Oncotarget; 2015 Jun; 6(18):16239-52. PubMed ID: 25938545 [TBL] [Abstract][Full Text] [Related]
28. NHE1 is upregulated in gastric cancer and regulates gastric cancer cell proliferation, migration and invasion. Xie R; Wang H; Jin H; Wen G; Tuo B; Xu J Oncol Rep; 2017 Mar; 37(3):1451-1460. PubMed ID: 28098891 [TBL] [Abstract][Full Text] [Related]
29. Gastrokine 1 inhibits gastric cancer cell migration and invasion by downregulating RhoA expression. Yoon JH; Choi WS; Kim O; Choi BJ; Nam SW; Lee JY; Park WS Gastric Cancer; 2017 Mar; 20(2):274-285. PubMed ID: 27250838 [TBL] [Abstract][Full Text] [Related]
30. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis. Okugawa Y; Toiyama Y; Hur K; Toden S; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Kusunoki M; Boland CR; Goel A Carcinogenesis; 2014 Dec; 35(12):2731-9. PubMed ID: 25280565 [TBL] [Abstract][Full Text] [Related]
31. Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C. Yang Q; Jie Z; Cao H; Greenlee AR; Yang C; Zou F; Jiang Y Carcinogenesis; 2011 May; 32(5):713-22. PubMed ID: 21349817 [TBL] [Abstract][Full Text] [Related]
32. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer. Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172 [TBL] [Abstract][Full Text] [Related]
33. Distinct subgroup of the Ras family member 3 (DIRAS3) expression impairs metastasis and induces autophagy of gastric cancer cells in mice. Qiu J; Li X; He Y; Sun D; Li W; Xin Y J Cancer Res Clin Oncol; 2018 Oct; 144(10):1869-1886. PubMed ID: 30043279 [TBL] [Abstract][Full Text] [Related]
34. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells. Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456 [TBL] [Abstract][Full Text] [Related]
35. miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway. Ma DH; Li BS; Liu JJ; Xiao YF; Yong X; Wang SM; Wu YY; Zhu HB; Wang DX; Yang SM Cancer Lett; 2017 Nov; 408():23-32. PubMed ID: 28842285 [TBL] [Abstract][Full Text] [Related]
36. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer. Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864 [TBL] [Abstract][Full Text] [Related]
37. VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance. Cho HJ; Kim IK; Park SM; Baek KE; Nam IK; Park SH; Ryu KJ; Choi J; Ryu J; Hong SC; Jeong SH; Lee YJ; Ko GH; Kim J; Won Lee C; Soo Kang S; Yoo J Int J Cancer; 2014 Oct; 135(7):1553-63. PubMed ID: 24585459 [TBL] [Abstract][Full Text] [Related]
38. Androgen receptor promotes gastric cancer cell migration and invasion via AKT-phosphorylation dependent upregulation of matrix metalloproteinase 9. Zhang BG; Du T; Zang MD; Chang Q; Fan ZY; Li JF; Yu BQ; Su LP; Li C; Yan C; Gu QL; Zhu ZG; Yan M; Liu B Oncotarget; 2014 Nov; 5(21):10584-95. PubMed ID: 25301736 [TBL] [Abstract][Full Text] [Related]
40. The microRNA-367 inhibits the invasion and metastasis of gastric cancer by directly repressing Rab23. Bin Z; Dedong H; Xiangjie F; Hongwei X; Qinghui Y Genet Test Mol Biomarkers; 2015 Feb; 19(2):69-74. PubMed ID: 25489984 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]